The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors : a quantitative systematic review

Fleming, Leanne and Agnew, Sommer and Peddie, Nicola and Crawford, Megan and Dixon, Diane and MacPherson, Iain (2022) The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors : a quantitative systematic review. The Breast, 64. pp. 63-84. ISSN 0960-9776 (https://doi.org/10.1016/j.breast.2022.04.010)

[thumbnail of Fleming-etal-Breast-2022-The-impact-of-medication-side-effects-on-adherence-and-persistence-to-hormone-therapy]
Preview
 Text. Filename: Fleming_etal_Breast_2022_The_impact_of_medication_side_effects_on_adherence_and_persistence_to_hormone_therapy.pdf
Final Published Version
License: Creative Commons Attribution 4.0 logo
Download (3MB)| Preview

Abstract

Background Hormone Therapy (HT) is recommended for most women with HR-positive primary breast cancer. When taken as intended, HT reduces breast cancer recurrence by 40% and mortality by one-third. The recommended duration of treatment ranges from 5 to 10 years depending on risk of recurrence and the specific HT regimen. However, recent data indicates that rates of HT non-adherence are high and research suggests this may be due to the impact of HT side effects. The contribution of side effects to non-adherence and non-persistence behaviours has rarely been systematically explored, thereby hindering the implementation of targeted intervention strategies. Our aim is to identify, evaluate and summarise the relationship between HT side effects and patterns of adherence and persistence. Methods Electronic searches were conducted from inception and were completed by September 2021, utilising Cochrane CENTRAL, Medline, Embase, Web of Science and PsycINFO databases. Searches included a combination of terms related to breast cancer, adherence, hormone therapy and side effects. Results Sixty-two eligible papers were identified and study quality varied by study type. Most observational and cross-sectional studies were rated good quality, whereas most controlled intervention studies were rated fair quality. Three studies were rated poor quality. The most frequently measured side effects were pain, low mood, hot flashes, insomnia, anxiety, fatigue, weight gain, concentration/memory problems. Conclusions This review identified a lack of consistency in the measurement of adherence and the definition of persistence across studies. The instruments used to measure side effects also varied significantly. This variation and lack of consistency makes it difficult to evaluate and summarise the role of HT side effects in HT adherence and persistence behaviour.

CORE (COnnecting REpositories)